Nothing Special   »   [go: up one dir, main page]

DE60035788D1 - MORAXELLA POLYPEPTIDE (BRANHAMELLA) CATARRHALIS - Google Patents

MORAXELLA POLYPEPTIDE (BRANHAMELLA) CATARRHALIS

Info

Publication number
DE60035788D1
DE60035788D1 DE60035788T DE60035788T DE60035788D1 DE 60035788 D1 DE60035788 D1 DE 60035788D1 DE 60035788 T DE60035788 T DE 60035788T DE 60035788 T DE60035788 T DE 60035788T DE 60035788 D1 DE60035788 D1 DE 60035788D1
Authority
DE
Germany
Prior art keywords
branhamella
catarrhalis
polypeptides
moraxella
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60035788T
Other languages
German (de)
Other versions
DE60035788T2 (en
Inventor
Joelle Thonnard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9921693.9A external-priority patent/GB9921693D0/en
Priority claimed from GBGB9921694.7A external-priority patent/GB9921694D0/en
Priority claimed from GBGB9922829.8A external-priority patent/GB9922829D0/en
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of DE60035788D1 publication Critical patent/DE60035788D1/en
Application granted granted Critical
Publication of DE60035788T2 publication Critical patent/DE60035788T2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention provides BASB129, BASB130 and BASB131 polypeptides and polynucleotides encoding BASB129, BASB130 and BASB131 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
DE60035788T 1999-09-14 2000-09-14 MORAXELLA POLYPEPTIDE (BRANHAMELLA) CATARRHALIS Expired - Lifetime DE60035788T2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9921693.9A GB9921693D0 (en) 1999-09-14 1999-09-14 Novel compounds
GBGB9921694.7A GB9921694D0 (en) 1999-09-14 1999-09-14 Novel compounds
GB9921693 1999-09-14
GB9921694 1999-09-14
GBGB9922829.8A GB9922829D0 (en) 1999-09-25 1999-09-25 Novel compounds
GB9922829 1999-09-25
PCT/EP2000/009034 WO2001019862A2 (en) 1999-09-14 2000-09-14 Polypeptides from moraxella (branhamella) catarrhalis

Publications (2)

Publication Number Publication Date
DE60035788D1 true DE60035788D1 (en) 2007-09-13
DE60035788T2 DE60035788T2 (en) 2008-04-30

Family

ID=27269798

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60035788T Expired - Lifetime DE60035788T2 (en) 1999-09-14 2000-09-14 MORAXELLA POLYPEPTIDE (BRANHAMELLA) CATARRHALIS

Country Status (7)

Country Link
EP (1) EP1214339B1 (en)
AT (1) ATE368686T1 (en)
AU (1) AU1383901A (en)
CA (1) CA2383081A1 (en)
DE (1) DE60035788T2 (en)
ES (1) ES2290056T3 (en)
WO (1) WO2001019862A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7341727B1 (en) * 1996-05-03 2008-03-11 Emergent Product Development Gaithersburg Inc. M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
CA2262748A1 (en) * 1996-08-12 1998-02-19 Board Of Regents, The University Of Texas System Defining epitopes of the outer membrane protein copb of moraxella catarrhalis

Also Published As

Publication number Publication date
ATE368686T1 (en) 2007-08-15
AU1383901A (en) 2001-04-17
CA2383081A1 (en) 2001-03-22
ES2290056T3 (en) 2008-02-16
WO2001019862A3 (en) 2001-10-04
EP1214339B1 (en) 2007-08-01
DE60035788T2 (en) 2008-04-30
WO2001019862A2 (en) 2001-03-22
EP1214339A2 (en) 2002-06-19

Similar Documents

Publication Publication Date Title
DE69921649D1 (en) MORAXELLA CATARRHALIS PILQ PROTEINE
ATE312922T1 (en) MORAXELLA CATARRHALIS POLYNUCLEOTIDES AND POLYPEPTIDES
ATE303442T1 (en) COMPOUNDS FROM MORAXELLA CATARRHALIS
PL345193A1 (en) Basb027 proteins and genes from moraxella catarrhalis
DE60043658D1 (en) BASB118 POLYPEPTIDE AND POLYNUCLEOTIDE FROM MORAXELLA CATARRHALIS
ATE397666T1 (en) NEW COMPOUNDS FROM MORAXELLA CATARRHALIS
DE60034463D1 (en) BASB119 POLYPEPTIDE AND POLYNUCLEOTIDE FROM MORAXELLA CATARRHALIS
DE60035788D1 (en) MORAXELLA POLYPEPTIDE (BRANHAMELLA) CATARRHALIS
ATE399205T1 (en) IMMUNOGENE POLYPEPTIDES FROM MORAXELLA CATARRHALIS AND USES THEREOF
ATE443715T1 (en) POLYPEPTIDES FROM HAEMOPHILUS INFLUENZA
ATE274582T1 (en) BASB028 POLYPEPTIDES AND POLYNUCLEOTIDES CODING THEREFOR FROM MORAXELLA CATARRHALIS
DE60019614D1 (en) MORAXELLA CATARRHALIS ANTIGEN BASB117
ATE311458T1 (en) BASB111 POLYPEPTIDE AND POLYNUCLEOTIDE FROM MORAXELLA CATHARRALIS
ATE293692T1 (en) MORAXELLA CATARRHALIS ANTIGEN BASB120
WO2001009333A3 (en) Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
WO2001009172A3 (en) Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition